CD14 and rheumatoid arthritis: Although no differences were seen in the numbers of CD62L+CD14+ cells (Figure 2f) prior to LFN therapy, CD62L expression was markedly reduced on CD14+ and PMN cells of NST RA patients in comparison with healthy subjects (Figure 2g,i).